📰 Eric Weinberg News
Eric Weinberg News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Eric Weinberg. Real-time updates on events, politics, business and more.
May 24, 2024
The judge came to the decision after days of testimony from Weinbergs alleged victims, who said they feared for their lives during the alleged assaults that occurred between 2014 and 2019.
May 23, 2024
The writer and producer was charged in October 2022 with sexually assaulting at least five women, prosecutors said.
May 23, 2024
Many of the women testified that agreed to meet Weinberg at his home. When they got there, the women said he would begin to take photos, then eventually, Weinberg either began to remove their clothing or groped himself.
May 22, 2024
'Scrubs' producer Eric Weinberg was ordered on Tuesday to stand trial on 28 counts of rape and sexual assault involving eight accusers.
May 22, 2024
Near two years after he was first arrested by the LAPD on multiple rape claims, the one-time high flying producer is finally going to trial
May 22, 2024
A Los Angeles judge reportedly ruled that former 'Scrubs' producer Eric Weinberg must stand trial for 28 charges of rape and sexual battery brought by eight women he allegedly abused.
April 23, 2024
RxSight, Inc. (NASDAQ:RXST – Get Free Report) has been given a consensus recommendation of “Buy” by the six analysts that are currently covering the company, Marketbeat reports. Six investment analysts have rated the stock with a buy rating. The average 1 year price target among analysts that have issued ratings on the stock in the […]
April 21, 2024
RxSight, Inc. (NASDAQ:RXST – Get Free Report) has earned an average recommendation of “Buy” from the six ratings firms that are currently covering the company, Marketbeat.com reports. Six investment analysts have rated the stock with a buy rating. The average 1-year price target among analysts that have issued ratings on the stock in the last […]
February 29, 2024
RxSight (NASDAQ:RXST – Get Free Report) had its target price raised by Oppenheimer from $54.00 to $61.00 in a research report issued on Thursday, Benzinga reports. The firm presently has an “outperform” rating on the stock. Oppenheimer’s price objective points to a potential upside of 8.73% from the company’s previous close. Several other equities analysts […]
February 27, 2024
RxSight (NASDAQ:RXST – Get Free Report) is set to release its earnings data after the market closes on Wednesday, February 28th. Analysts expect RxSight to post earnings of ($0.36) per share for the quarter. Persons interested in participating in the company’s earnings conference call can do so using this link. RxSight Price Performance Shares of […]